Drug - International Biopharmaceutical Industry

news

Amid biotech downturn, Atlas raises $450M to build new drug startups

Dive Brief: Atlas Venture, a prolific creator of biotech startups, has raised $450 million to form and invest in new drug companies, announcing Thursday the closin...

4 March 2022 news Atlas | Biotech

Continue Reading →

news

Roche, nearing major trial readouts, starts new Alzheimer’s drug study

Dive Brief: Roche is expanding clinical testing of its experimental Alzheimer's disease drug gantenerumab, announcing Thursday the start of a late-stage trial in p...

4 March 2022 news Aduhelm | Alzheimer

Continue Reading →

news

FDA sets back Karyopharm’s bid to broaden use of cancer drug

Dive Brief: Karyopharm Therapeutics will have to perform a new clinical trial to widen the use of its cancer drug selinexor after U.S. regulators said the results ...

4 March 2022 news cancer | Drug

Continue Reading →

news

AstraZeneca, Daiichi press rivals with new results for breast cancer drug

Dive Brief: AstraZeneca and Daiichi Sankyo's antibody drug Enhertu could become standard treatment for a large group of breast cancer patients following Phase 3 st...

24 February 2022 news AstraZeneca | breast

Continue Reading →

news

Adagio pledges to press forward with COVID drug as CEO to resign

Dive Brief: Adagio Therapeutics CEO Tillman Gerngross has agreed "in principle" to resign as head of the COVID-19 drug developer amid confusion over whether its mo...

24 February 2022 news Adagio | Adimab

Continue Reading →

news

Sage claims new data show depression drug works, but doubts remain

Dive Brief: An experimental, fast-acting depression drug from Sage Therapeutics and partner Biogen met its main goals in a closely watched Phase 3 study that is me...

18 February 2022 news Biogen | depression

Continue Reading →

news

Al Sandrock, former top Biogen scientist, to join drug discovery startup’s board

Dive Brief: Al Sandrock, a former top Biogen executive who led development of the company's Alzheimer's drug Aduhelm, is joining the board of directors at Verge Ge...

10 February 2022 news Al Sandrock | Alzheimer

Continue Reading →

news

Why the FDA is making a test case of a cancer drug from China

At a quick glance, the Food and Drug Administration's decision to ask its advisers for help in vetting yet another cancer immunotherapy may seem odd. After all, the ...

10 February 2022 news cancer | china

Continue Reading →

news

Pressure rises as Gilead awaits important study results for top cancer drug

Gilead lost several billion dollars in market value Wednesday after unnerving investors with updates about a key clinical trial of its most closely watched breast can...

10 February 2022 news cancer | clinical

Continue Reading →

news

Pressure rises as Gilead awaits important study results for top cancer drug

Gilead lost several billion dollars in market value Wednesday after unnerving investors with updates about a key clinical trial of its most closely watched breast can...

6 February 2022 news cancer | Drug

Continue Reading →